In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor prognosis. The main treatment for MPM is doublet chemotherapy with Cisplatin and Pemetrexed, while ongoing trials test the efficacy of pemetrexed monotherapy. However, there is lack of evidence regarding the effects of Cisplatin...
Main Authors: | Eleftherios D. Papazoglou, Rajesh M. Jagirdar, Olympia A. Kouliou, Eleanna Pitaraki, Chrissi Hatzoglou, Konstantinos I. Gourgoulianis, Sotirios G. Zarogiannis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/10/1446 |
Similar Items
-
Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01) -
Analysis of the Efficacy of Pemetrexed Maintenance Therapy in Patients with
Malignant Pleural Mesothelioma
by: Xiaomei ZENG, et al.
Published: (2022-01-01) -
Systemic treatment in patients with malignant pleural mesothelioma – real life experience
by: Barbara Ziółkowska, et al.
Published: (2022-04-01) -
Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology
by: Georgia Karpathiou, et al.
Published: (2022-03-01) -
In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma
by: Erasmia Rouka, et al.
Published: (2019-06-01)